Antiviral therapies for managing viral hepatitis in lymphoma patients.

about

Risk of hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients with undetectable serum HBV DNA after treatment with rituximab for lymphoma: a meta-analysis.Patients With Isolated Hepatitis B Core Antibody: Has the Time Come to Vaccinate?

P2860

Q38601007-6F955A1E-54F1-4E8D-8593-FA88FBA27349 Q50094267-EE471FC6-7D9F-4DA0-A3A3-A4720019FB00

P2860

Antiviral therapies for managing viral hepatitis in lymphoma patients.

Item

http://www.wikidata.org/entity/Q38989625

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Antiviral therapies for managing viral hepatitis in lymphoma patients.

@en

type

Item

label

Antiviral therapies for managing viral hepatitis in lymphoma patients.

@en

prefLabel

Antiviral therapies for managing viral hepatitis in lymphoma patients.

@en

P1476

Antiviral therapies for managing viral hepatitis in lymphoma patients

@en

P2093

Manuel Gotti

http://www.w3.org/2001/XMLSchema#string

Sara Rattotti

http://www.w3.org/2001/XMLSchema#string

P2860

Hepatitis C-associated B-cell non-Hodgkin lymphomas. Epidemiology, molecular signature and clinical management

Chronic hepatitis B: update 2009

Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection

Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection

Comparison of entecavir and lamivudine in preventing HBV reactivation in lymphoma patients undergoing chemotherapy: a meta-analysis.

Prevalence and estimation of hepatitis B and C infections in the WHO European Region: a review of data focusing on the countries outside the European Union and the European Free Trade Association.

Long-lasting complete remission of hepatitis C virus (HCV) infection and HCV-associated immunocytoma with alpha-interferon treatment.

Acute flares in chronic hepatitis B: the natural and unnatural history of an immunologically mediated liver disease.

Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naïve patients is rare through 5 years of therapy.

Lymphoma Remission by Interferon-Free HCV Eradication Without Chemotherapy.

P304

363-376

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14656566.2017.1288718

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Luca Arcaini

Michele Merli

P577

2017-02-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28140702

http://www.w3.org/2001/XMLSchema#string

Antiviral therapies for managing viral hepatitis in lymphoma patients.

about

P2860

P2860

Antiviral therapies for managing viral hepatitis in lymphoma patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698